SELLAS Life Sciences Shares Fall; Interim Trial Results on Acute Myeloid Leukemia Treatment Issued

In This Article:

SELLAS Life Sciences Group (SLS) shares fell 14% in recent Thursday trading after the company announ

Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.